Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Tibet Duo Rui Pharmaceutical
301075
4
ChengDu Sheng Nuo Biotec
688117
5
Shenzhen Kaifa Technology
920029
US Stock MarketDetailed Quotes
CTNM Contineum Therapeutics
- 7.070
- -0.380-5.10%
Close Mar 28 16:00 ET
- 7.070
- 0.0000.00%
Post 16:00 ET
182.91MMarket Cap-4.33P/E (TTM)
7.575High7.005Low48.92KVolume7.550Open7.450Pre Close348.82KTurnover0.37%Turnover RatioLossP/E (Static)25.87MShares22.00052wk High0.92P/B92.83MFloat Cap5.92052wk Low--Dividend TTM13.13MShs Float22.000Historical High--Div YieldTTM7.65%Amplitude5.920Historical Low7.130Avg Price1Lot Size
Contineum Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 50M | 0 | 0 | 50M | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --50M | --0 | --0 | --50M | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 50.03%50.89M | 76.18%17.05M | 60.79%12.97M | -1.08%10.94M | 94.13%9.93M | 49.31%33.92M | 77.57%9.68M | 8.07M | 11.06M | 5.12M |
| Selling and administrative expenses | 97.34%12.47M | 142.31%4.03M | 106.75%3.25M | 89.83%3.04M | 45.11%2.15M | 8.48%6.32M | 11.30%1.66M | --1.57M | --1.6M | --1.48M |
| -General and administrative expense | 97.34%12.47M | 142.31%4.03M | 106.75%3.25M | 89.83%3.04M | 45.11%2.15M | 8.48%6.32M | 11.30%1.66M | --1.57M | --1.6M | --1.48M |
| Research and development costs | 39.20%38.42M | 62.44%13.02M | 49.68%9.73M | -16.48%7.9M | 114.15%7.78M | 63.39%27.6M | 102.63%8.01M | --6.5M | --9.46M | --3.63M |
| Operating profit | -416.56%-50.89M | -76.18%-17.05M | -60.79%-12.97M | -128.11%-10.94M | -94.13%-9.93M | 170.76%16.08M | -77.57%-9.68M | -8.07M | 38.94M | -5.12M |
| Net non-operating interest income expense | 102.48%8.91M | 41.23%2.53M | 57.89%2.74M | 255.42%2M | 429.45%1.64M | 1,079.09%4.4M | 642.74%1.79M | 1.74M | 563K | 309K |
| Non-operating interest income | 93.33%8.91M | 41.23%2.53M | 57.89%2.74M | 194.70%2M | 307.98%1.64M | 505.26%4.61M | 423.39%1.79M | --1.74M | --679K | --401K |
| Non-operating interest expense | --0 | --0 | --0 | --0 | --0 | -46.39%208K | --0 | --0 | --116K | --92K |
| Other net income (expense) | -109.98%-269K | -4.55%-46K | 5.56%-34K | -102.36%-66K | -583.33%-123K | 241.40%2.7M | 98.09%-44K | -36K | 2.79M | -18K |
| Gain on sale of security | -2,220.00%-106K | -66.67%1K | ---- | 450.00%11K | ---117K | 66.67%5K | 200.00%3K | ---- | --2K | ---- |
| Special income (charges) | --0 | --0 | --0 | --0 | ---- | 257.79%2.87M | --0 | --0 | --2.87M | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | -257.79%-2.87M | --0 | ---- | ---2.87M | ---- |
| Other non- operating income (expenses) | 7.91%-163K | 0.00%-47K | 5.56%-34K | -1.32%-77K | 66.67%-6K | -92.39%-177K | -370.00%-47K | ---36K | ---76K | ---18K |
| Income before tax | -282.38%-42.26M | -83.67%-14.57M | -61.20%-10.27M | -121.30%-9.01M | -74.48%-8.42M | 195.53%23.17M | -5.56%-7.93M | -6.37M | 42.29M | -4.82M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 450K | -161K | -118K | 729K | 0 |
| Net income | -285.99%-42.26M | -87.48%-14.57M | -64.25%-10.27M | -121.68%-9.01M | -74.48%-8.42M | 193.68%22.72M | -3.42%-7.77M | -6.25M | 41.56M | -4.82M |
| Net income continuous Operations | -285.99%-42.26M | -87.48%-14.57M | -64.25%-10.27M | -121.68%-9.01M | -74.48%-8.42M | 193.68%22.72M | -3.42%-7.77M | ---6.25M | --41.56M | ---4.82M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -285.99%-42.26M | -87.48%-14.57M | -64.25%-10.27M | -121.68%-9.01M | -74.48%-8.42M | 193.68%22.72M | -3.42%-7.77M | -6.25M | 41.56M | -4.82M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 0 | 0 | 35.7M | ||||||
| Net income attributable to common stockholders | -285.99%-42.26M | -179.24%-14.57M | -64.25%-10.27M | -253.50%-9.01M | -74.48%-8.42M | 193.68%22.72M | 344.68%18.38M | -6.25M | 5.87M | -4.82M |
| Basic earnings per share | -359.60%-2.18 | -182.43%-0.56 | -73.13%-0.4 | -210.80%-0.39 | -7.53%-0.3111 | 157.73%0.8397 | 250.79%0.6793 | -0.231 | 0.352 | -0.2893 |
| Diluted earnings per share | -359.60%-2.18 | -182.43%-0.56 | -73.13%-0.4 | -334.88%-0.39 | -7.53%-0.3111 | 157.73%0.8397 | 250.79%0.6793 | -0.231 | 0.166 | -0.2893 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call